The science behind BIOEFFECT EGF Serum


Loading Player

Follow us on:

Latest news

2011-10-03

Best results I have seen during my 30 years of practice, says renowned Professor of Dermatology, Dr. Ronald L. Moy, about BIOEFFECT EGF Serum


“These are the best res20MYNF08190911 Ronald 23.jpgults I have seen with a topical treatment, during my 30 years of practice as a dermatologist,” says renowned US dermatologist, Dr. Ronald L. Moy, when describing the efficacy of the BIOEFFECT EGF Serum.

Dr. Moy studied the efficacy of the BIOEFFECT EGF Serum on patients at his clinic in Beverly Hills in Los Angeles. He presented the results at a lecture for Icelandic dermatologist and media on September 19th.

Describing the main results of his study, Dr. Moy said: “The skin of the participants, which were women aged 39-75, became softer, wrinkles were reduced and the skin became visibly tighter, after three months of use. Pores were significantly reduced, red and brown pigmentation was reduced and the overall complexion of the skin was much improved.”

In an interview on national TV news, Dr. Moy said: “The BIOEFFECT EGF Serum is far more impressive than anything I have seen for anti-aging and for tightening. In fact, it rivals some of the procedures we dermatologists do to tighten skin, so I have been very impressed.

The Epidermal Growth Factor made in Iceland is unique; it is unlike any other growth factor in the world. It is bioengineered from barley, whereas all other growth factors are made in E. coli bacteria. The one that is made in Iceland is much more stable since it is made from barley. That is why we have found this to be the most effective Epidermal Growth Factor and why the patients universally said that it improves their skin.

It is not from Paris, it is not from Switzerland, where we may think beauty products come from. But maybe the new skin care products that will help all of us in the future will come from Iceland.”

Dr. Ronald L. Moy is a professor of dermatology at UCLA's David Geffen School of Medicine and President of the American Academy of Dermatology. His study is to be published in a peer-reviewed scientific journal.